A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Incyte Corporation
Exelixis
Incyte Corporation
Pfizer
Incyte Corporation
Eli Lilly and Company
Gilead Sciences
Incyte Corporation
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
National Cancer Institute (NCI)
University of Kansas Medical Center
Roswell Park Cancer Institute
Fox Chase Cancer Center
INSYS Therapeutics Inc